Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN394194

Wilms Tumor 1 (WT1) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33, CWT1, XWT1b, XeWT1, wt-1, wt1, xwt1, WT1, WT, XWT1a, xWT1, si:ch211-160j6.3, zgc:152697, gud, wagr, wt33, wit-2
»Alternatives Human
»Alternatives Mouse
Clonality (Clone) Monoclonal ()
»Alternatives Un-conjugated
»Alternatives ELISA, Western Blotting (WB)
Pubmed 5 references available
Catalog no. ABIN394194
Quantity 0.1 mg
450.00 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 2 to 3 Business Days
Immunogen WT1 (NP_000369, 349 a.a. ~ 439 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 K
Clone 2H4
Isotype IgG2b kappa
Specificity WT1 (NP_000369, 349 a.a. ~ 439 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Purification This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name WT1
Background Synonyms: Serine protease inhibitor J6, 47 kDa heat shock protein, Collagen-binding protein, Colligin, Serpin H1,Hsp47, Cbp1, Serpinh1
Molecular Weight 49188 DA
Gene ID 12406
UniProt NP_000369
Research Area Translation Factors, Cancer, Transcription Factors, Signaling, Cell Structure
Application Notes ELISA ~~ 1ug/ml~3ng/ml Western blot ~~ 1:500~1000

Background: This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.

Restrictions For Research Use only
Buffer PBS with 0.09% (w/v) sodium azide.
Preservative Sodium azide
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Machuca, Benoit, Nevo et al.: "Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome." in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 7, pp. 1209-17, 2010 (PubMed).

Bachas, Schuurhuis, Hollink et al.: "High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine." in: Blood, Vol. 116, Issue 15, pp. 2752-8, 2010 (PubMed).

Borbulevych, Do, Baker: "Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics." in: Molecular immunology, Vol. 47, Issue 15, pp. 2519-24, 2010 (PubMed).

Hollink, van den Heuvel-Eibrink, Zimmermann et al.: "No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 28, pp. e523-6; author reply e527-e528, 2010 (PubMed).

Rocquain, Carbuccia, Trouplin et al.: "Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias." in: BMC cancer, Vol. 10, pp. 401, 2010 (PubMed).

Alternatives for antigen "Wilms Tumor 1 (WT1)", type "Antibodies"
Hosts (48), (38), (6)
Reactivities (89), (30), (29), (15), (14), (13), (12), (1), (1), (1), (1)
Applications (60), (38), (23), (21), (14), (10), (10), (7), (3), (3), (3), (2), (1), (1)
Conjugates (3), (3), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Epitopes (10), (8), (8), (6), (2), (2), (2), (2), (1), (1), (1), (1), (1)